Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 6/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL719105 | 0.85 | CTSA (0.43) | CTSAACHEALDH1A1L3MBTL1GAA | |
| SCHEMBL1459532 | 0.83 | CTSA (0.48) | CTSAACHEALDH1A1L3MBTL1GAA | |
| SCHEMBL10910619 | 0.80 | CTSA (0.50) | CTSAACHEALDH1A1L3MBTL1GAA | |
| SCHEMBL7163625 | 0.78 | CTSA (0.48) | CTSAACHEALDH1A1L3MBTL1GAA | |
| SCHEMBL3446843 | 0.77 | CTSA (0.37) | CTSAACHEGAAATM | |
| SCHEMBL4758253 | 0.77 | CTSA (0.37) | CTSAACHEALDH1A1GAAATM | |
| SCHEMBL9068827 | 0.77 | CTSA (0.37) | CTSAACHEALDH1A1L3MBTL1GAA | |
| SCHEMBL29148026 | 0.77 | CTSA (0.37) | CTSAACHEGAAATMHMGCR | |
| SCHEMBL6014466 | 0.75 | CTSA (0.46) | CTSAACHEALDH1A1L3MBTL1GAA | |
| SCHEMBL10832923 | 0.75 | CTSA (0.46) | CTSAACHEALDH1A1L3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633127-B2 | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-01-21 | — | — | US | claimed |
| EP-1437336-B1 | METHOD OF SEPARATING/PURIFYING CONJUGATED DIENE AND SEPARATION/PURIFICATION APPARATUS | ZEON CORP (JP) | 2012-05-30 | — | — | EP | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| EP-4365250-A1 | MIGRATION-PREVENTING COATING AGENT | Sakata INX Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-11616253-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-03-28 | — | — | US | disclosed |
| US-20220278370-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-09-01 | — | — | US | disclosed |
| US-11367899-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| EP-3144064-B1 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-07-28 | — | — | EP | disclosed |
| CN-1624587-A | Hydrogenated ring-opening metathesis polymer and process for producing the same | MITSUI CHEMICALS INC (JP) | 2005-06-08 | — | — | CN | disclosed |
| CN-1616607-A | Additive for increasing anti-oxidation stability of diesel oil | LEITE CHEMICAL SCIENCE AND TEC (CN) | 2005-05-18 | — | — | CN | disclosed |
| US-6841061-B1 | Antigelling agent for hydrocarbon mixture containing conjugated diene and method of preventing clogging of apparatus for separating and purifying the mixture | ZEON CORPORATION (JP) | 2005-01-11 | — | — | US | disclosed |
| US-20040267078-A1 | Method of separating/purifying conjugated diene and separation/purification apparatus | ZEON CORPORATION (JP) | 2004-12-30 | — | — | US | disclosed |
| US-6770222-B1 | HYDROXYLAMINES AND PHOSPHORUS CONTAINING COMPOUND | NIPPON ZEON CO., LTD. (JP) | 2004-08-03 | — | — | US | disclosed |
| EP-1437336-A1 | METHOD OF SEPARATING/PURIFYING CONJUGATED DIENE AND SEPARATION/PURIFICATION APPARATUS | NIPPON ZEON CO., LTD. (JP) | 2004-07-14 | — | — | EP | disclosed |
| EP-1184444-A1 | ANTIGELLING AGENT FOR HYDROCARBON MIXTURE CONTAINING CONJUGATED DIENE AND METHOD OF PREVENTING CLOGGING OF APPARATUS FOR SEPARATING AND PURIFYING THE MIXTURE | Nippon Zeon Co., Ltd. (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-1061059-A1 | POLYMERIZATION-INHIBITING COMPOSITION, POLYMERIZATION INHIBITOR AND METHOD FOR INHIBITING POLYMERIZATION | NIPPON ZEON CO., LTD. (JP) | 2000-12-20 | — | — | EP | disclosed |
| US-4480692-A | HYDROCARBON SULFONATE | PHILLIPS PETROLEUM COMPANY (US) | 1984-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040267078-A1 | Method of separating/purifying conjugated diene and separation/purification apparatus | AKR7A2, DDAH1, DHPS | CTSA 4798/4885ACHE 562/4885ALDH1A1 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.